Pedalitin
Based on 2 publication(s) in Google Scholar
Pedalitin is a tyrosinase and α-glucosidase inhibitor with IC50 values of 0.28 mM and 0.29 mM, respectively, and can be isolated and extracted from Rabdosia serra. Pedalitin is a xanthine oxidase (Xanthine Oxidase) (IC50 = 3.7 µM) and myeloperoxidase (MPO) (IC50 = 3.8 nM) inhibitor. Pedalitin ameliorates NAFLD by downregulating the EGFR/IRS1/AKT1/FOXO1 signaling pathway and related inflammatory and lipid metabolism factors. Pedalitin reduces the risk of urinary tract infection and stones by inhibiting the expression of the urease UreC gene in Proteus mirabilis. Pedalitin also exhibits antifungal activity, with a MIC of 3.9 mg/L against Cryptococcus neoformans. Pedalitin can be used for research on non-alcoholic fatty liver disease, chronic kidney disease, kidney stones, cryptococcosis, and abdominal pain.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.67%
- CAS 番号: 22384-63-0
- 分子式: C16H12O7
- 分子量:316.26
-
保管条件:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
生物活性
製品説明
|
α-Glucosidase 0.29 mM (IC50) |
MPO 3.8 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
131.7 mg/L
|
Cytotoxicity against human HepG2 cells assessed as concentration at which 50% of cells were killed after 24 hrs exposure by MTT assay.
Cytotoxicity against human HepG2 cells assessed as concentration at which 50% of cells were killed after 24 hrs exposure by MTT assay.
|
27742203 |
| MRC5 | IC50 |
191.7 mg/L
|
Cytotoxicity against human MRC-5 cells assessed as concentration at which 50% of cells were killed after 24 hrs exposure by MTT assay.
Cytotoxicity against human MRC-5 cells assessed as concentration at which 50% of cells were killed after 24 hrs exposure by MTT assay.
|
27742203 |
| U-87MG ATCC | IC50 |
175 mg/L
|
Cytotoxicity against human U87-MG cells assessed as concentration at which 50% of cells were killed after 24 hrs exposure by MTT assay.
Cytotoxicity against human U87-MG cells assessed as concentration at which 50% of cells were killed after 24 hrs exposure by MTT assay.
|
27742203 |
体外実験
Pedalitin (1 mg/L; 30 min-2 h) combined with Amphotericin B (HY-B0221) significantly reduces Cryptococcus neoformans infection in U87-MG cells and MRC-5 cells[10].
Pedalitin exhibited potent MPO inhibitory activity, ABTS radical scavenging activity, and DPPH radical scavenging activity, with IC50 values of 3.8 nM, 1.4 μM, and 5.2 μM, respectively[3].
Pedalitin significantly inhibits urease activity in the enzymatic reaction solution extracted from Proteus mirabilis[5].
Pedalitin (0.12-62.5 mg/L; 24 h) exhibited low cytotoxicity in HepG2, MRC-5, NOK, and U87-MG cell lines, with IC50 values of 131.7, 191.7, 119, and 175 mg/L, respectively[10].
Pedalitin (0.01-0.4 mM; pre-incubation for 2-5 min) significantly inhibited tyrosinase and α-glucosidase activities, with IC50 values of 0.28 mM and 0.29 mM, respectively[11].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LO2
-
Concentration:20, 40, 80 μM
-
Incubation Time:24 h (FFA induction); 1 h (CCK-8)
-
Result:Reduced cell viability to around 80% at 40 and 80 μM.
-
Cell Line:LO2
-
Concentration:20 μM
-
Incubation Time:24 h
-
Result:Significantly inhibited FFA-induced upregulation of TNF-α and IL-17 mRNA expression.
Restored CPT2 and HADH mRNA expression levels to near-normal ranges.
Restored expression levels of EGFR, IRS-1, AKT-1, and FOXO1 genes within the FOXO signaling pathway to a balanced state.
-
Cell Line:U87-MG, MRC-5
-
Concentration:4 mg/L
-
Incubation Time:30 min, 1 h, 2 h
-
Result:Reduced infection by approximately 50% after 30 min in both cell types.
Reduced infection to approximately 60% in lung fibroblasts after 2 h.
Reduced infection to approximately 40% in glioblastoma cells after 2 h.
体内実験
Pedalitin (10 mg/kg; intraperitoneal injection; once daily; 40 days) combined with Amphotericin B has a synergistic effect, improving the survival rate, fungal burden, and histopathology of BALB/c mice infected with C. neoformans[8].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD1 (male, 25-30 g)[9]
-
Dosage:1, 5, 10 mg/kg
-
Administration:i.p.; single dose; 30 min
-
Result:Decreased the number of writhes significantly from a minimum dose of 1 mg/kg, producing at least 50% inhibition of nociception.
-
Animal Model:BALB/c mice[10]
-
Dosage:40 mg/kg
-
Administration:i.p.; once daily; 40 days
-
Result:Significantly prolonged the survival of mice.
Achieved 60% and 40% survival after 20 and 40 days, respectively, with combination therapy.
Significantly decreased the fungal burden in both lungs and brain.
Reduced fungal burden by 48% in lungs and brain after 7 days.
Reduced the number of colonies by >80% in both organs after 14 days.
Significantly reduced the number of yeasts in histopathological analysis after 14 days.
Product Details
-
Structure Classification
-
Initial Source
化学情報
-
CAS 番号 22384-63-0
-
性状 Solid
-
分子量 316.26
-
分子式 C16H12O7
-
Color Light yellow to yellow
-
SMILES
O=C1C=C(C2=CC=C(O)C(O)=C2)OC3=CC(OC)=C(O)C(O)=C13
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Food Chem
Flavonoid-mediated metabolic underpinning quality variation in red bud-sport pear mutants. [Abstract]2025 Oct 15:489:144992. PMID: 40466530 -
純度とドキュメンテーション
参考文献
[3]. Fernandes DC, et al. Myeloperoxidase inhibitory and radical scavenging activities of flavones from Pterogyne nitens. Chemical & pharmaceutical bulletin. 2008 May;56(5):723-6. [Content Brief]
[11]. Lin L, et al. Comparative evaluation of rosmarinic acid, methyl rosmarinate and pedalitin isolated from Rabdosia serra (MAXIM.) HARA as inhibitors of tyrosinase and α-glucosidase. Food Chem. 2011 Dec 1;129(3):884-9. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)